ReviewFrontiers in nutrition2026
The current status and emerging trends in the application of precision nutrition for the comprehensive, lifecycle-based management of chronic liver diseases.
Review in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic liver disease (CLD) is defined as a progressive deterioration of hepatic function lasting for more than 6 months, which poses a significant challenge to global public health due to its high rates of morbidity, disability, and mortality. Traditional nutritional management often fails to meet the individualized needs of patients at different stages of disease progression and throughout their lifespan. In this context, precision nutritional intervention-a dietary approach-has garnered increasing attention in the management of CLD, due to its core advantages of dynamic optimization management strategies based on individual metabolic characteristics. This study provides a narrative review and critical analysis of the theoretical foundations, current applications, and recent advancements in precision nutrition interventions for managing CLD. Additionally, it highlights existing gaps, practical challenges, and potential directions for future research and clinical applications. The main objective is to demonstrate how multidisciplinary collaborative innovation covering hepatology, nutrition, bioinformatics, and health technology, and the optimization of supporting technologies, can accelerate the clinical transformation and widespread application of precision nutrition interventions in CLD. Ultimately, this approach aims to provide robust evidence-based decision support for developing an efficient, highly individualized health management system that encompasses prevention, treatment, and rehabilitation, thereby providing substantial clinical and public health benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.